Intrinsiqs

Is Inovio Pharmaceuticals, Inc. overvalued?

Inovio Pharmaceuticals, Inc. (INO) — key valuation metrics and fundamentals.

No verdict
Price
$1.09
Fair value
Current P/E
Normal P/E
Market cap
$75.3M
Dividend yield
36.0%
Return on equity
-666.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares INO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.